The product is being recalled due to a market complaint received, stating that one bottle labeled as 30-count telmisartan tablets 20 mg incorrectly contained 30 tablets of 40-mg telmisartan tablets.
Bridgewater, NJ, Alembic Pharmaceuticals, Inc is voluntarily recalling one lot of Telmisartan Tablets, USP, 20 mg, packaged in 30-count bottles, Lot No. 1905005661 to the consumer level. The product ...
Telmisartan (Micardis, Boehringer Ingelheim), a nonpeptide AT-II-receptor antagonist, gained FDA approval for use in the treatment of hypertension in 1998. After oral administration, peak ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Telmisartan (Telmitrust (40 mg)) is angiotensin ...
Alembic Pharmaceuticals has recalled one lot of 20mg telmisartan tablets because the bottles may actually contain 40mg tablets. According to an announcement with the U.S. Food and Drug Administration, ...
Prolonged lowering of blood pressure after a stroke reduces the risk of recurrent stroke. In addition, inhibition of the renin–angiotensin system in high-risk patients reduces the rate of subsequent ...
Chika E. Okereke, MD; Franz H. Messerli, MD, Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA A total of 57% of ...
Angiotensin II receptor blockers have beneficial effects in patients with cardiac diseases. We examined the effects of an angiotensin II receptor blocker, telmisartan, on cardiac remodeling in ...
Increased left ventricular mass (LVM) is an independent risk factor for cardiovascular morbidity and mortality in patients with hypertension. 1 Therefore, left ventricular hypertrophy (LVH) regression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback